Bayer Warns Planned German Price Curbs May Restrict Drug AccessBy , , and
Germany looking at revenue ceiling for drugs in first year
Government also considering extending cap on older drugs
Bayer AG, Roche Holding AG and other drugmakers are warning that a German government proposal to tighten price controls on prescription drugs could end up restricting access to new medicines in Europe’s biggest health-care market.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.